Gene therapy of pituitary diseases

Journal of Endocrinology

Volumn 185, Issue 3, 2005, Pages 353-362

  Lee, Eun Jig ^a   Jameson, J Larry ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADENOVIRUS VECTOR; BETA GALACTOSIDASE; COMPLEMENTARY DNA; CRE RECOMBINASE; DIPHTHERIA TOXIN; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FULVESTRANT; GANCICLOVIR; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR RECEPTOR; LENTIVIRUS VECTOR; LIPOSOME; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PARVOVIRUS VECTOR; PRODRUG; PROLACTIN; PROOPIOMELANOCORTIN; PROTEIN P16; RECOMBINANT GROWTH HORMONE; RETINOBLASTOMA PROTEIN; SOMATOSTATIN DERIVATIVE; THYMIDINE KINASE; TYROSINE 3 MONOOXYGENASE; VASOPRESSIN; VIRUS VECTOR;

ALPHA CHAIN; DRUG EFFICACY; GENE EXPRESSION; GENE THERAPY; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; HYPOPHYSIS TUMOR; HYPOPITUITARISM; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; REVIEW; VIRAL GENE THERAPY;

ADENOMA; ANIMALS; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPITUITARISM; MODELS, ANIMAL; PITUITARY DISEASES; PITUITARY NEOPLASMS; VASOPRESSINS;

EID: 21244474380     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06023     Document Type: Review

References (88)

1. Acsadi G, Lochmuller H, Jani A, Huard J, Massie B, Prescott S, Simoneau M, Petrof BJ & Karpati G 1996 Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Human Gene Therapy 7 129-140.
2. Ahangari G, Ostadali MR, Rabani A, Rashidian J, Sanati MH & Zarindast MR 2004 Growth hormone antibodies formation in patients treated with recombinant human growth hormone. International Journal of Immunopathology and Pharmacology 17 33-38.
3. Al-Hendy A, Hortelano G, Tannenbaum GS & Chang PL 1995 Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts-an alternate approach to somatic gene therapy. Human Gene Therapy 6 165-175.
4. Al-Hendy A, Hortelano G, Tannenbaum GS & Chang PL 1996 Growth retardation-an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts. Human Gene Therapy 7 61-70.
5. Ali M, Lemonine N & Ring CJA 1994 The use of DNA viruses as vectors for gene therapy. Gene Therapy 1 367-384.
6. Anton M & Graham FL 1995 Site-specific recombination mediated by an adenovirus vector expressing the cre recombinase protein: a molecular switch for control of gene expression. Journal of Virology 69 4600-4606.
7. Beck-Peccoz P & Persani L 2002 Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 5 83-88.
8. Bienemann AS, Martin-Rendon E, Cosgrave AS, Glover CP, Wong LF, Kingsman SM, Mitrophanous KA, Mazarakis ND & Uney JB 2003 Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin. Molecular Therapy 7 588-596.
9. Biron KK, Stanat SC, Sorrell JB, Fyfe JA, Keller PM, Lambe CU & Nelson DJ 1985 Metabolic activation of the nucleoside analog 9-[(2-hyroxy-1-(hydroxymethyl)ethoxy] methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus. PNAS 82 2473-2477.
10. Bodine D, Jameson JL & McKay R 2005 Stem cell and gene transfer in clinical medicine. In Harrison's Principles of Internal Medicine, edn 16, pp 392-397. Eds DL Kasper, E Braunwald, AS Fauci, SL Hauser, DL Longo & JL Jameson. New York: McGraw-Hill Companies, Inc.
11. Bolognani F, Albarino C, Romanowski V, Carri NG & Goya RG 2001 In vitro and in vivo herpetic vector-mediated gene transfer in the pituitary gland: impact on hormone secretion. European Journal of Endocrinology 145 497-503.
12. Boson WL, Sarubi JC, d'Alva CB, Friedman E, Faria D, De Marco L & Wajchenberg B 2003 A signal peptide mutation of the arginine vasopressin gene in monozygotic twins. Clinical Endocrinology 58 108-110.
13. Buning H, Nicklin SA, Perabo L, Hallek M & Baker AH 2003 AAV-based gene transfer. Current Opinion in Molecular Therapy 5 367-375.
14. Carter PJ & Samulski RJ 2000 Adeno-associated viral vectors as gene delivery vehicles. International Journal of Molecular Medicine 6 17-27.
15. Castro MG, Goya RG, Sosa YE, Rowe J, Larregina A, Morelli A & Lowenstein PR 1997 Expression of transgenes in normal and neoplastic anterior pituitary cells using recombinant adenoviruses: long term expression, cell cycle dependency, and effects on hormone secretion. Endocrinology 138 2184-2194.
16. Chaidarun SS, Swearingen B & Alexander JM 1998 Differential expression of estrogen receptor-beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant. Journal of Clinical Endocrinology and Metabolism 83 3308-3315.
17. Chien PY, Ito M, Park Y, Tagami T, Gehm BD & Jameson JL 1999 A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells. Molecular Endocrinology 13 2122-2136.
18. Davis JR, McVerry J, Lincoln GA, Windeatt S, Lowenstein PR, Castro MG & McNeilly AS 2001 Cell type-specific adenoviral transgene expression in the intact ovine pituitary gland after stereotaxic delivery: an in vivo system for long- term multiple parameter evaluation of human pituitary gene therapy. Endocrinology 142 795-801.
19. Davis JR, McMahon RF, Lowenstein PR, Castro MG, Lincoln GA & McNeilly AS 2002 Adenovirus-mediated gene transfer in the ovine pituitary gland is associated with hypophysitis. Journal of Endocrinology 173 265-271.
20. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM & Blau HM 1991 Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254 1509-1512.
21. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D & Naldini L 1998 A third-generation lentivirus vector with a conditional packaging system. Journal of Virology 72 8463-8471.
22. Elion GB 1982 Mechanism of action and selectivity of acyclovir. American Journal of Medicine 73 7-13.
23. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N et al. 2000 Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nature Medicine 6 568-572.
24. Freese A, During MJ, Davidson BL, Gennarelli TA, Kaplitt MG, Flamm ES & Snyder PJ 1996 Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release. Journal of Clinical Endocrinology and Metabolism 81 2401-2404.
25. Geddes BJ, Harding TC, Lightman SL & Uney JB 1997 Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nature Medicine 3 1402-1404.
26. Graham FL & Prevec L 1991 Manupulation of adenovirus vectors. In Methods in Molecular Biology, pp 109-128. Ed. EJ Murray. Clifton, NJ: The Humana Press.
27. Hahn TM, Copeland KC & Woo SL 1996 Phenotypic correction of dwarfism by constitutive expression of growth hormone. Endocrinology 137 4988-4993.
28. Hamid O, Varterasian ML, Wadler S, Hecht JR, Benson A 3rd, Galanis E, Uprichard M, Omer C, Bycott P, Hackman RC et al. 2003 Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer. Journal of Clinical Oncology 21 1498-1504.
29. Haynes P, Lambert TR & Mitchell ID 1996 Comparative in-vivo genotoxicity of antiviral nucleotide analoques; penciclovir, ganciclovir and xanthine analogue, caffeine, in the mouse bone marrow micronucleus assay. Mutation Research 369 65-74.
30. Heartlein MW, Roman VA, Jiang JL, Sellers JW, Zuliani AM, Treco DA & Selden RF 1994 Long-term production and delivery of human growth hormone in vivo. PNAS 91 10967-10971.
31. Horwitz MS 1990 Adenoviridae and their replication. In Virology, pp 1679-1721. Eds BN Fields, DM Knipe et al. [q; 4 Can you give the names of the other editors?] New York: Raven Press.
32. Huard J, Lochmuller H, Acsadi G, Jani A, Massie B & Karpati G 1995 The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Therapy 2 107-115.
33. Hull KL & Harvey S 2003 Growth hormone therapy and Quality of Life: possibilities, pitfalls and mechanisms. Journal of Endocrinology 179 311-333.
34. Hurwitz DR, Kirchgesser M, Merrill W, Galanopoulos T, McGrath CA, Emami S, Hansen M, Cherington V, Appel JM, Bizinkauskas CB et al. 1997 Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Human Gene Therapy 8 137-156.
35. Ideno J, Mizukami H, Honda K, Okada T, Hanazono Y, Kume A, Saito T, Ishibashi S & Ozawa K 2003 Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing arginine-vasopressin in Brattleboro rats. Molecular Therapy 8 895-902.
36. Ilsley DD, Lee SK, Miller WH & Kuchta RD 1995 Acyclic guanosine analogs inhibiy DNA polymerase α, β and ε with very different potencies and have unique mechanisms of action. Biochemistry 34 2504-2510.
37. Inazawa T, Tanabe T, Yamada H, Nakaoka T, Hashimoto Y, Yamasaki T, Kotaki H, Tani K, Asano S & Yamashita N 2001 Glucocorticoid-regulated expression of exogenous human growth hormone gene in rats. Molecular Therapy 4 267-272.
38. Ince BA, Zhuang Y, Wrenn CK, Shapiro DJ & Katzenellenbogen BS 1993 Powerful dominant negative mutants of the human estrogen receptor. Journal of Biological Chemistry 268 14026-14032.
39. Ince BA, Schodin DJ, Shapiro DJ & Katzenellenbogen BS 1995 Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors. Endocrinology 136 3194-3199.
40. Ito M, Mori Y, Oiso Y & Saito H 1991 A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus. Journal of Clinical Investigation 87 725-728.
41. Jolly D 1994 Viral vector systems for gene therapy. Cancer Gene Therapy 1 51-64.
42. Kirn D 2001a Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials. Expert Opinion on Biological Therapy 1 525-538.
43. Kirn D 2001b Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Therapy 8 89-98.
44. Kojima H, Fujimiya M, Matsumura K, Younan P, Imaeda H, Maeda M & Chan L 2003 NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nature Medicine 9 596-603.
45. Krasnykh VN, Mikheeva GV, Douglas JT & Curiel DT 1996 Generation of recominant adenovirus vectors with modified fibers for altering viral tropism. Journal of Virology 70 6839-6846.
46. Lazennec G, Alcorn JL & Katzenellenbogen BS 1999 Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation. Molecular Endocrinology 13 969-980.
47. Lee EJ & Jameson JL 1997 Gonadotropin (FSH and LH) pituitary tumors. In Disease of the pituitary. Diagnosis and treatment, pp 247-272. Ed. ME Wierman. Totowa: Humana Press Inc.
48. Lee EJ & Jameson JL 2002 Cell-specific cre-mediated activation of the diphtheria toxin gene in pituitary tumor cells: potential for cytotoxic gene therapy. Human Gene Therapy 13 533-542.
49. Lee EJ, Kim KR, Lim SK, Lee HC, Kim DI, Kim SH & Huh KB 1994 Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog). European Journal of Endocrinology 131 109-112.
50. Lee EJ, Anderson LM, Thimmapaya B & Jameson JL 1999 Targeted expression of toxic genes directed by pituitary hormone promoters: a potential strategy for adenovirus-mediated gene therapy of pituitary tumors. Journal of Clinical Endocrinology and Metabolism 84 786-794.
51. Lee EJ, Thimmapaya B & Jameson JL 2000 Stereotactic injection of adenoviral vectors that target gene expression to specific pituitary cell types: implications for gene therapy. Neurosurgery 46 1461-1468; discussion 1468-1469.
52. Lee EJ, Duan WR, Kotlar T & Jameson JL 2001a Restoration of growth hormone-releasing hormone (GHRH) responsiveness in pituitary GH3 cells by adenovirus-directed expression of the human GHRH receptor. Endocrinology 142 414-420.
53. Lee EJ, Duan WR, Jakacka M, Gehm BD & Jameson JL 2001b Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cells and inhibits tumor growth in nude mice. Endocrinology 142 3756-3763.
54. Lee EJ, Martinson F, Kotlar T, Thimmapaya B & Jameson JL 2001c Adenovirus-mediated targeted expression of toxic genes to adrenocorticotropin-producing pituitary tumors using the proopiomelanocortin promoter. Journal of Clinical Endocrinology and Metabolism 86 3400-3409.
55. Lee EJ, Jakacka M, Duan WR, Chien PY, Martinson F, Gehm BD & Jameson JL 2001d Adenovirus-directed expression of dominant negative estrogen receptor induces apoptosis in breast cancer cells and regression of tumors in nude mice. Molecular Medicine 7 773-782.
56. MacColl GS, Novo FJ, Marshall NJ, Waters M, Goldspink G & Bouloux PM 2000 Optimisation of growth hormone production by muscle cells using plasmid DNA. Journal of Endocrinology 165 329-336.
57. Melmed S 1997 General aspects of the management of pituitary tumors by surgery or radiation therapy. In Endocrinology, edn 3, pp 497-503. Ed. LJ DeGroot. Philadelphia: W.B. Saunders Co.
58. Melmed S, Vance ML, Barkan AL, Bengtsson BA, Kleinberg D, Klibanski A & Trainer PJ 2002 Current status and future opportunities for controlling acromegaly. Pituitary 5 185-196.
59. Merriam GR, Carney C, Smith LC & Kletke M 2004 Adult growth hormone deficiency: current trends in diagnosis and dosing. Journal of Pediatrics Endocrinology and Metabolism 17 Suppl 4 1307-1320.
60. Miller WH & Miller RL 1980 Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. Journal of Biological Chemistry 255 7204-7207.
61. Miller WH & Miller RL 1982 Phosphorylation of acyclovir diphosphate by cellular enzyme. Biochemical Pharmacology 31 3879-3884.
62. Moolten FL 1986 Tumor chemosensitivity conferred by inserted herpes thymidine kinase gene: paradigm for a prospective cancer control strategy. Cancer Research 46 5276-5281.
63. Morris JC, Touraine R, Wildner O & Blaese RM 1999 Suicide genes: gene therapy applications using enzyme/prodrug strategies. In The Development of Human Gene Therapy, pp 477-526. Ed. T Friedmann. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
64. Nagasaki H, Ito M, Yuasa H, Saito H, Fukase M, Hamada K, Ishikawa E, Katakami H & Oiso Y 1995 Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus. Journal of Clinical Endocrinology and Metabolism 80 1352-1356.
65. Nemunaitis J, Khuri F, Ganly I, Arseneau J, Posner M, Vokes E, Kuhn J, McCarty T, Landers S, Blackburn A et al. 2001 Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. Journal of Clinical Oncology 19 289-298.
66. Newton CJ 1995 Estrogen receptor blockade by the pure antiestrogen, ZM 182780, induces death of pituitary tumour cells. Journal of Steroid Biochemistry and Molecular Biology 55 327-336.
67. Piston DW, Knobel SM, Postic C, Shelton KD & Magnuson MA 1999 Adenovirus-mediated knockout of a conditional glucokinase gene in isolated pancreatic islets reveals an essential role for proximal metabolic coupling events in glucose-stimulated insulin secretion. Journal of Biological Chemistry 274 1000-1004.
68. Rabinowitz JE & Samulski RJ 2000 Building a better vector: the manipulation of AAV virions. Virology 278 301-308.
69. Reid T, Galanis E, Abbruzzese J, Sze D, Andrews J, Romel L, Hatfield M, Rubin J & Kirn D 2001 Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Therapy 8 1618-1626.
70. Riley DJ, Nikitin AU & Lee WH 1996 Adenovirus-mediated retinoblastoma gene therapy suppress spontaneous pituitary melanotroph tumors in Rb+/- mice. Nature Medicine 2 1316-1321.
71. Russell TA, Ito M, Yu RN, Martinson FA, Weiss J & Jameson JL 2003 A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. Journal of Clinical Investigation 112 1697-1706.
72. Sato N, Wang S, Li L, Okabe K, Hashimoto M, Yaginuma H, Mikoshiba K, Uchiyama Y, Uetsuki T, Yoshikawa K et al. 1998a A novel strategy for introducing exogenous bcl-2 into neuronal cells: the Cre/loxP system-mediated activation of bcl-2 for preventing programmed cell death using recombinant adenoviruses. Molecular and Cellular Neurosciences 12 65-78.
73. Sato Y, Tanaka K, Lee G, Kanegae Y, Sakai Y, Kaneko S, Nakabayashi H, Tamaoki T & Saito I 1998b Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector. Biochemical and Biophysical Research Communications 244 455-462.
74. Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL & Kochanek S 1998 Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature Genetics 18 180-183.
75. Schlechte JA 1997 Differential diagnosis and management of hyperprolactinemia. In Disease of the pituitary. Diagnosis and treatment, edn 1, pp 71-77. Ed. ME Wierman. Totowa: Humana Press Inc.
76. Schwarzenberger P, Spence SE, Gooya JM, Michiel D, Curiel DT, Ruscetti FW & Keller JR 1996 Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 87 472-478.
77. Shupnik MA, Pitt LK, Soh AY, Anderson A, Lopes MB & Laws ER Jr 1998 Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism 83 3965-3972.
78. Smith-Arica JR, Williams JC, Stone D, Smith J, Lowenstein PR & Castro MG 2001 Switching on and off transgene expression within lactotrophic cells in the anterior pituitary gland in vivo. Endocrinology 142 2521-2532.
79. Southgate TD, Windeatt S, Smith-Arica J, Gerdes CA, Perone MJ, Morris I, Davis JR, Klatzmann D, Lowenstein PR & Castro MG 2000 Transcriptional targeting to anterior pituitary lactotrophic cells using recombinant adenovirus vectors in vitro and in vivo in normal and estrogen/sulpiride-induced hyperplastic anterior pituitaries. Endocrinology 141 3493-3505.
80. Southgate TD, Stone D, Williams JC, Lowenstein PR & Castro MG 2001 Long-term transgene expression within the anterior pituitary gland in situ: impact on circulating hormone levels, cellular and antibody-mediated immune responses. Endocrinology 142 464-476.
81. Stec DE, Davisson RL, Haskell RE, Davidson BL & Sigmund CD 1999 Efficient liver-specific deletion of a floxed human angiotensinogen transgene by adenoviral delicery of cre recombinase in vivo. Journal of Biological Chemistry 274 21285-21290.
82. Vecil GG & Lang FF 2003 Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolyric adenoviruses. Journal of Neurooncology 65 237-246.
83. Wickham TJ, Carrion ME & Kovesdi I 1995 Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Therapy 2 750-756.
84. Wickham TJ, Tzeng E, Shears LL, Roelvink PW, Li Y, Lee GM, Brough DE, Lizonova A & Kovesdi I 1997 Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. Journal of Virology 71 8221-8229.
85. Williams JC, Stone D, Smith-Arica JR, Morris ID, Lowenstein PR & Castro MG 2001 Regulated, adenovirus-mediated delivery of tyrosine hydroxylase suppresses growth of estrogen-induced pituitary prolactinomas. Molecular Therapy 4 593-602.
86. Windeatt S, Southgate TD, Dewey RA, Bolognani F, Perone MJ, Larregina AT, Maleniak TC, Morris ID, Goya RG, Klatzmann D et al. 2000 Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas. Journal of Clinical Endocrinology and Metabolism 85 1296-1305.
87. Wyatt D 2004 Lessons from the national cooperative growth study. European Journal of Endocrinology 151 Suppl 55-59.
88. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L & Trono D 1998 Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. Journal of Virology 72 9873-9880.